Literature DB >> 17344708

The prevalence of rheumatoid arthritis in the Qassim region of Saudi Arabia.

A Al-Dalaan1, S Al Ballaa, S Bahabri, T Biyari, M Al Sukait, M Mousa.   

Abstract

BACKGROUND: Although rheumatoid arthritis (RA) of varying degrees of severity has been seen in our clinics, there is no statistical evidence of the magnitude of the problem in Saudi nationals. We conducted this study to determine the prevalence of RA in the Al Qassim Region of Saudi Arabia. PATIENTS AND METHODS: Five thousand eight hundred and ninety-one Saudi adults, aged 16 years and over, were studied in a house-to-house survey in the Al Qassim Region.
RESULTS: Of the 5891 adults studied, 13 cases of RA were identified, using the criteria set for the diagnosis of RA by the American College of Rheumatology. Thirty-five percent of our patients showed positive rheumatoid factor.
CONCLUSION: The prevalence of RA in Al Qassim was estimated at 2.2 per thousand people. It was also noted that the prevalence of the disease increased with age, and that it was more common in females.

Entities:  

Year:  1998        PMID: 17344708     DOI: 10.5144/0256-4947.1998.396

Source DB:  PubMed          Journal:  Ann Saudi Med        ISSN: 0256-4947            Impact factor:   1.526


  16 in total

1.  The Prevalence and the Determinants of Musculoskeletal Diseases in Emiratis Attending Primary Health Care Clinics in Dubai.

Authors:  Jamal Al Saleh; Manal El Sayed; Nahed Monsef; Ebtihal Darwish
Journal:  Oman Med J       Date:  2016-03

2.  The prevalences of some rheumatic diseases in western Turkey: Havsa study.

Authors:  Necati Cakır; Ömer Nuri Pamuk; Emine Derviş; Neşe Imeryüz; Haşim Uslu; Ömer Benian; Edip Elelçi; Genco Erdem; Fatma Oğuz Sarvan; Mustafa Senocak
Journal:  Rheumatol Int       Date:  2011-01-13       Impact factor: 2.631

3.  The spectrum of rheumatoid arthritis in patients attending rheumatology clinic in nizwa hospital-oman.

Authors:  Faisal Al-Temimi
Journal:  Oman Med J       Date:  2010-07

4.  Suboptimal management of rheumatoid arthritis in the Middle East and Africa: could the EULAR recommendations be the start of a solution?

Authors:  Bassel El Zorkany; Humaid A Alwahshi; Mohamed Hammoudeh; Samar Al Emadi; Romela Benitha; Adel Al Awadhi; Elyes Bouajina; Ahmed Laatar; Samir El Badawy; Marzooq Al Badi; Mustafa Al-Maini; Jamal Al Saleh; Ramiz Alswailem; Mahmood Moosa Tar Mahomed Ally; Wafaa Batha; Hachemi Djoudi; Ayman El Garf; Khaled El Hadidi; Mohamed El Marzouqi; Musa Hadidi; Ajesh Basantharan Maharaj; Abdel Fattah Masri; Ayman Mofti; Ibrahim Nahar; Clive Allan Pettipher; Catherine Elizabeth Spargo; Paul Emery
Journal:  Clin Rheumatol       Date:  2012-12-30       Impact factor: 2.980

5.  Hyperlipidemia in rheumatoid arthritis patients in Saudi Arabia. Correlation with C-reactive protein levels and disease activity.

Authors:  Suzan M Attar
Journal:  Saudi Med J       Date:  2015-06       Impact factor: 1.484

6.  Early Diagnosis Of Inflammatory Arthritis By Primary Care Physicians Following Training By A Rheumatologist.

Authors:  Rami Magliah; Waleed Hafiz; Ziad Abdulaziz Alahmadi; Muhammad Irfanullah Siddiqui; Haytham Mohamed Ahmed; Suzan Mansour Attar; Nahed Janoudi; Hani Almoallim
Journal:  Open Access Rheumatol       Date:  2019-12-13

7.  Extra-articular manifestations of rheumatoid arthritis: a hospital-based study.

Authors:  Aisha Al-Ghamdi; Suzan M Attar
Journal:  Ann Saudi Med       Date:  2009 May-Jun       Impact factor: 1.526

Review 8.  Rheumatoid arthritis in Saudi Arabia.

Authors:  Hani M Almoallim; Laila A Alharbi
Journal:  Saudi Med J       Date:  2014-12       Impact factor: 1.484

9.  Validation of the Arabic version of the early inflammatory arthritis detection tool.

Authors:  K Al-Jarallah; D Shehab; M A A Moussa; M Abraham
Journal:  Med Princ Pract       Date:  2013-07-26       Impact factor: 1.927

Review 10.  An Overview of the Intrinsic Role of Citrullination in Autoimmune Disorders.

Authors:  Mohammed Alghamdi; Doaa Alasmari; Amjad Assiri; Ehab Mattar; Abdullah A Aljaddawi; Sana G Alattas; Elrashdy M Redwan
Journal:  J Immunol Res       Date:  2019-11-25       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.